NASDAQ : PTN
Palatin Technologies, Inc. — Key statistics
Healthcare · Biotechnology · United States
Last price 5.0465 USD (Oct 30, 2026, 10:03 AM EDT) · Market cap 9.81M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 9.58M |
| Enterprise Value | 2.31M |
Dates
| Measure | Value |
|---|
| Earnings Date | Sep 28, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 1.78M |
| Shares Outstanding | 1.78M |
| Shares Change (YoY) | +425.17% |
| Shares Change (QoQ) | +0.24% |
| Owned by Insiders (%) | 4.91% |
| Owned by Institutions (%) | 42.83% |
| Float | 1.56M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.73 |
| Forward PS | 1.15 |
| PB Ratio | 1.43 |
| P/TBV Ratio | 1.43 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.18 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 4.61 |
| Quick Ratio | 4.40 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,288.77 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -877.53% |
| Return on Assets (ROA) | -91.90% |
| Return on Invested Capital (ROIC) | -471.74% |
| Return on Capital Employed (ROCE) | -128.38% |
| Weighted Average Cost of Capital (WACC) | 4.14% |
| Revenue Per Employee | $527,401 |
| Profits Per Employee | -$335,116 |
| Employee Count | 25 |
| Asset Turnover | 2.24 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | -0.01 |
| 52-Week Price Change | -15.25% |
| 50-Day Moving Average | 9.15 |
| 200-Day Moving Average | 14.04 |
| Relative Strength Index (RSI) | 25.27 |
| Average Volume (20 Days) | 33,277 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 332,220 |
| Short Previous Month | 364,901 |
| Short % of Shares Out | 18.65% |
| Short % of Float | 21.25% |
| Short Ratio (days to cover) | 8.33 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 13.19M |
| Gross Profit | 816,158 |
| Operating Income | -8.67M |
| Pretax Income | -8.38M |
| Net Income | -8.38M |
| EBITDA | -8.61M |
| EBIT | -8.67M |
| Loss Per Share | -$2.99 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 7.49M |
| Total Debt | 223,679 |
| Net Cash | 7.27M |
| Net Cash Per Share | $4.08 |
| Equity (Book Value) | 6.69M |
| Book Value Per Share | 3.76 |
| Working Capital | 6.39M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -13.53M |
| Capital Expenditures | -51,299 |
| Depreciation & Amortization | 62,679 |
| Net Borrowing | n/a |
| Free Cash Flow | -13.58M |
| FCF Per Share | -$7.63 |
Margins
| Measure | Value |
|---|
| Gross Margin | 6.19% |
| Operating Margin | -65.74% |
| Pretax Margin | -63.54% |
| Profit Margin | -63.54% |
| EBITDA Margin | -65.27% |
| EBIT Margin | -65.74% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -425.17% |
| Shareholder Yield | -425.17% |
| Earnings Yield | -59.84% |
| FCF Yield | -141.78% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $53.50 |
| Price Target Difference | 970.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | -73.33% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Aug 12, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:50 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -69.43 |
| Piotroski F-Score | 1 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |